Newsletter Subject

Fauci Positive for COVID

From

medpagetoday.com

Email Address

daily.headlines@broadcaster3.medpagetoday.com

Sent On

Sat, Jun 18, 2022 11:19 AM

Email Preheader Text

Weekly Review Saturday, June 18, 2022 WORDOSIS CME SPOTLIGHT ADVERTISEMENT CME SPOTLIGHT CME SPOTLIG

[MEDPAGE TODAY]( Weekly Review Saturday, June 18, 2022 [Fauci Positive for COVID]( [America's Frontline Doctors' Simone Gold Gets Prison Time]( [New Hampshire Hospital Lost Nearly 8 Gallons of Fentanyl]( WORDOSIS [Play Today's Wordosis: Our Medical Word Game]( CME SPOTLIGHT [Transforming HR+/HER2- Breast Cancer Care: Real-world Patient and Provider Perspectives]( ['There Is Something Wrong With My Body']( [We're Not Out of the Pandemic Woods Yet]( ADVERTISEMENT [Bariatric Surgery and Cancer Risk; Obesity and Type 1 Diabetes]( CME SPOTLIGHT [Immunotherapy in Advanced Melanoma: Evidence-Based Adverse Event Management Strategies to Improve Patient Outcomes]( [Transplant Success Without Immune Suppressive Drugs]( [Peril in Paradise: Rat Lungworm's Threat in Tropical Getaways]( [Parents of 4-Year-Old Sue Urologist for 'Unintentional Vasectomy']( CME SPOTLIGHT [Achieving Health Equity in Multiple Myeloma: Interprofessional Roles and Opportunities]( [Vitamin C and Sepsis: Data Turn Sour, Suggesting Harm]( [Less Fluid Not Better for Septic Shock]( [I Just Recovered From BA.2. Can I Get BA.4/5?]( CME SPOTLIGHT [Shared Decision-Making as a Tool for Optimizing Management of Adverse Events]( ['I'm a Neurosurgeon Who Can't Move. Now What?']( [COVID Toddler Vax Clears Major Hurdle]( [The Healing Power of 'I Don't Know']( CME SPOTLIGHT [Advancing Clinical Decision-Making in Myelofibrosis Care: Focus on Symptom Recognition and Risk Stratification]( [N-of-1 Tests Sway Statin Naysayers; Synthetic Chemicals and BP; TAVR in Moderate AS?]( [SCOTUS Hands 340B Hospitals a Victory]( [AMA Annual Meeting Marred by Election Violation Charge]( CME SPOTLIGHT [Advancing Clinical Decision-Making in Myelofibrosis Care: Focus on Treatment Decision-Making]( [Prediabetes May be an Independent Risk Factor for MI]( [FDA Approves First Systemic Treatment for Alopecia Areata]( [COVID mRNA Vaccines Safe, Effective for Babies and Toddlers, Says FDA Staff]( CME SPOTLIGHT [Overcoming Barriers to Equitable Care for Patients with Multiple Myeloma]( [How Vaccine Immunity, Prior Infection Hold Up Against BA.2]( [Brain Symptoms Persist in Long COVID]( [Paxlovid Rebound Incidence Low, Study Suggests]( CME SPOTLIGHT [Incorporating Evidence-Based Guidelines Into Personalized Treatment Decision-Making for Multiple Myeloma]( [TAVR Pacemaker Rate Dips to Single Digits Nationwide, but Outlier Hospitals Remain]( [More Evidence Kawasaki Disease Trigger Is Something in the Air]( [Omicron Less Likely to Cause Long COVID, Data Suggest]( [Gun Violence Is a Scourge That Must Be Dealt With, Says Outgoing AMA President]( Meeting Coverage Can't get away? MedPage Today brings you extensive coverage of more than 80 meetings in a wide range of specialties. [SEE ALL STORIES >]( Got a news tip? MedPage Today offers several ways to provide information to our journalists securely and confidentially. [LEARN MORE >]( [EVERYDAY HEALTH]( © 2022 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_DHE_Weekly?xid=nl_mpt_DHE_2022-06-18&eun=g1020308d0r) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 345 Hudson Street 16th Floor New York, NY 10014

Marketing emails from medpagetoday.com

View More
Sent On

08/12/2024

Sent On

08/11/2024

Sent On

07/11/2024

Sent On

07/11/2024

Sent On

06/11/2024

Sent On

04/11/2024

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.